INFLAMMATORY BREAST CANCER

Basit Öğe Kaydı
dc.authoridDeveci, Uğur/0000-0003-4449-1190en_US
dc.contributor.authorKebudi, Abut
dc.contributor.authorDeveci, Uğur
dc.date.accessioned2024-07-12T21:40:52Z
dc.date.available2024-07-12T21:40:52Z
dc.date.issued2012en_US
dc.department[Belirlenecek]en_US
dc.description.abstractInflammatory breast cancer is one of the rarest and most aggressive forms of breast cancer, having relatively distinct clinicopathological features and the lowest survival rates. It has characteristic clinical findings, but may be confused with locally advanced breast cancer, which can present with the same physical findings. Biopsy can certainly help confirm the diagnosis. This type of breast cancer has not benefited significantly from the recent advances that have been made for the more common forms of the breast cancer. Breast conserving surgery for inflammatory breast cancer is contraindicated. Radical mastectomy alone for this disease resulted in less than a 5% survival rate at 5 years. Currently, the management of inflammatory breast cancer requires a multidisciplinary approach, which combines chemotherapy, surgery, and radiotherapy. This combination has improved the 5-year overall survival to 50%.en_US
dc.identifier.endpage62en_US
dc.identifier.issn2149-1976
dc.identifier.issue2en_US
dc.identifier.startpage55en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/7530
dc.identifier.volume8en_US
dc.identifier.wosWOS:000218548600001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofJournal of Breast Healthen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY09365
dc.subjectInflammationen_US
dc.subjectBreasten_US
dc.subjectCanceren_US
dc.titleINFLAMMATORY BREAST CANCERen_US
dc.typeReview Article
dspace.entity.typePublication

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu